James A. McCubrey
Impact in
- Oncology top 0.1%
- Cancer-related Molecular Pathways
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 0.2%
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 103
- Melanoma and MAPK Pathways 50
- Protein Kinase Regulation and GTPase Signaling 31
- Cell death mechanisms and regulation 28
- Oncology 135
- Cancer-related Molecular Pathways 46
- Cytokine Signaling Pathways and Interactions 34
- Co-authors
- Linda S. Steelman (113 shared papers)Richard A. Franklin (55 shared papers)Alberto M. Martelli (133 shared papers)Massimo Libra (86 shared papers)Camilla Evangelisti (55 shared papers)Patrick M. Navolanic (16 shared papers)Stephen L. Abrams (58 shared papers)William L. Blalock (28 shared papers)
- Journals
- Leukemia (53 papers)Advances in Biological Regulation (43 papers)Oncotarget (39 papers)Cell Cycle (39 papers)Blood (24 papers)
- Partner nations
- United StatesItalyPoland
In The Last Decade
James A. McCubrey
423 papers receiving 25.3k citations
James A. McCubrey's Hit Papers
Peers
Comparison fields: 5 of 170
- Oncology 6.3k
- Cancer Research 3.5k
- Hematology 2.5k
- Molecular Biology 15.2k
- Immunology 3.0k
Countries citing papers authored by James A. McCubrey
This map shows the geographic impact of James A. McCubrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. McCubrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. McCubrey more than expected).
Fields of papers citing papers by James A. McCubrey
This network shows the impact of papers produced by James A. McCubrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. McCubrey. The network helps show where James A. McCubrey may publish in the future.
Co-authors
The 25 scholars most cited alongside James A. McCubrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 425 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance Hit paper breakdown → | 2006 | 1918 |
| 2 | Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy Hit paper breakdown → | 2003 | 1021 |
| 3 | Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways Hit paper breakdown → | 2006 | 695 |
| 4 | Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention Hit paper breakdown → | 2003 | 599 |
| 5 | JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis Hit paper breakdown → | 2004 | 573 |
| 6 | Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance Hit paper breakdown → | 2006 | 565 |
| 7 | Transfer of specificity by murine α and β T-cell receptor genes Hit paper breakdown → | 1986 | 494 |
| 8 | Cutaneous melanoma: From pathogenesis to therapy (Review) Hit paper breakdown → | 2018 | 451 |
| 9 | 2014 | 413 | |
| 10 | 2008 | 393 | |
| 11 | Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). | 2003 | 341 |
| 12 | 2008 | 320 | |
| 13 | 1993 | 287 | |
| 14 | 2014 | 232 | |
| 15 | 2013 | 223 | |
| 16 | 2011 | 211 | |
| 17 | 2002 | 207 | |
| 18 | 2020 | 207 | |
| 19 | 2010 | 206 | |
| 20 | 2008 | 197 |
About James A. McCubrey
James A. McCubrey is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Cancer Research, having authored 425 papers that have together received 25.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (103 papers), Melanoma and MAPK Pathways (50 papers), Cancer-related Molecular Pathways (46 papers), Cytokine Signaling Pathways and Interactions (34 papers), Protein Kinase Regulation and GTPase Signaling (31 papers), Cell death mechanisms and regulation (28 papers), Acute Lymphoblastic Leukemia research (27 papers) and Chronic Lymphocytic Leukemia Research (25 papers). The work is most often cited by research in Oncology (6.3k citations), Cancer Research (3.5k citations), Hematology (2.5k citations), Molecular Biology (15.2k citations) and Immunology (3.0k citations). James A. McCubrey has collaborated with scholars based in United States, Italy and Poland. Frequent co-authors include Linda S. Steelman, Richard A. Franklin, Alberto M. Martelli, Massimo Libra, Camilla Evangelisti, Patrick M. Navolanic, Stephen L. Abrams, William L. Blalock, Francesca Chiarini and Franca Stivala. Their work appears in journals such as Leukemia, Advances in Biological Regulation, Oncotarget, Cell Cycle and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.